Amphastar Pharmaceuticals, Inc. (AMPH) Stock buybacks 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$75.6MFY2025 · since FY2016: $9.9M → $75.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.6M | -11.6% |
| FY2024 | $85.5M | +47.0% |
| FY2023 | $58.1M | +45.7% |
| FY2022 | $39.9M | +38.2% |
| FY2021 | $28.9M | +18.2% |
| FY2020 | $24.4M | +9.6% |
| FY2019 | $22.3M | -11.0% |
| FY2018 | $25.0M | -18.5% |
| FY2017 | $30.7M | +210.3% |
| FY2016 | $9.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice